Aarti Drugs Ltd.

View in App
500.75 +0.90 ▲0.2%

24 April 2024, 04:11:41 PM
Volume: 76,028

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.aartidrugs.com
Market Cap 4,608.70 Cr.
Enterprise Value(EV) 5,195.87 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 19.60 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 25.58 Trailing Twelve Months Ending 2023-12
Industry PE 41.22 Trailing Twelve Months Ending 2023-12
Book Value / Share 135.55 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.70 Calculated using Price: 501.30
Dividend Yield 0.20 Period Ending 2023-03
No. of Shares Subscribed 9.19 Cr. 91,935,000 Shares
FaceValue 10
About Aarti Drugs Ltd.
Aarti Drugs (ADL), incorporated in 1984, is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals. The company is part of $265 million Aarti Group of Industries.

Aarti Drugs Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Aarti Drugs Ltd. Performance

View details >>
1 Day
+0.18%
1 Week
+1.21%
1 Month
+9.91%
3 Month
-6.48%
6 Month
+3.41%
1 Year
+18.31%
2 Year
+1.92%
5 Year
+220.62%
10 Year
+1013.27%

Aarti Drugs Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 32.78 20.65 21.6 19.24 17.97 23.65 35.81 21.03 14.93
Return on Capital Employed (%) 23.93 17.95 18.14 17.31 17.01 21.39 34.52 20.75 15.49
Return on Assets (%) 10.13 6.53 7.13 6.38 6.31 9.33 16.78 10.32 7.19

Aarti Drugs Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 308 357 400 455 543 652 913 1,036 1,192 1,209
Non Curr. Liab. 211 244 297 312 321 301 257 232 296 309
Curr. Liab. 483 501 494 622 591 623 595 940 933 833
Minority Int. 0 0 0 0
Equity & Liab. 1,002 1,102 1,191 1,389 1,455 1,577 1,766 2,208 2,421 2,352
Non Curr. Assets 476 537 620 653 671 673 709 815 929 1,014
Curr. Assets 526 565 571 737 784 899 1,057 1,393 1,492 1,338
Misc. Exp. not W/O
Total Assets 1,002 1,102 1,191 1,389 1,455 1,577 1,766 2,208 2,421 2,352

Aarti Drugs Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 1,097 1,140 1,195 1,244 1,561 1,806 2,155 2,489 2,716 2,651
Other Income 1 4 1 2 1 5 11 2 4
Total Income 1,098 1,140 1,199 1,245 1,563 1,808 2,159 2,500 2,718 2,655
Total Expenditure -925 -960 -1,005 -1,042 -1,350 -1,541 -1,714 -2,156 -2,407 -2,327
PBIDT 173 180 194 203 213 267 445 344 312 328
Interest -42 -48 -40 -38 -44 -37 -26 -24 -37 -33
Depreciation -31 -37 -38 -40 -43 -49 -50 -50 -50 -50
Taxation -22 -27 -34 -42 -41 -44 -89 -65 -58 -64
Exceptional Items 4 4 0
PAT 77 69 82 82 90 141 280 205 166 180
Minority Interest 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 77 69 82 82 90 141 280 205 166 180
Adjusted EPS 8 7 9 9 10 15 30 22 18 20

Aarti Drugs Ltd. Cash Flow

View details >>
Particulars 10 years 2011-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 21 105 133 175 70 143 251 155 70 134
Cash Fr. Inv. -76 -107 -99 -107 -74 -62 -33 -72 -150 -164
Cash Fr. Finan. 53 1 -33 -68 4 -80 -215 -81 92 17
Net Change -3 -1 1 0 0 1 2 2 13 -13
Cash & Cash Eqvt 5 4 5 3 3 5 7 9 22 8

Aarti Drugs Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 59.83 59.98 59.77 59.66 59.58 58.70 58.56 57.47 57.13
Public 40.17 40.02 40.23 40.34 40.42 41.30 41.44 42.53 42.87
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Aarti Drugs Ltd. Announcements

View details >>
Tue, 23 Apr 2024
Updates
Aarti Drugs Limited has informed the Exchange regarding 'US FDA inspection at Formulations (Oncology) manufacturing facility of our Subsidiary (Pinnacle Life Science Private Limited) at Baddi, Himachal Pradesh '.
Fri, 05 Apr 2024
Loss of Share Certificates
Aarti Drugs Limited has informed the Exchange about Loss of Share Certificates
Fri, 05 Apr 2024
Loss/Duplicate-Share Certificate-XBRL
AARTI DRUGS LIMITED has informed the Exchange about Loss of share certificates

Aarti Drugs Ltd. Technical Scans

View details >>
Wed, 24 Apr 2024
Making Higher Highs for 3 days Making Higher Highs for 3 days
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Increase in 1 Month High Increase in 1 Month
High Increase in 5 Years High Increase in 5 Years
MFI Above 80 MFI Above 80

Aarti Drugs Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 356,625.15 1,485.75 +0.1%
Cipla Ltd. 112,938.41 1,398.20 +3.8%
Divi's Laboratories Ltd. 101,314.76 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. 99,276.89 5,950.80 0.0%
Mankind Pharma Ltd. 96,143.23 2,398.30 +0.2%
Zydus Lifesciences Ltd. 93,921.88 933.50 -2.7%
Torrent Pharmaceuticals Ltd. 90,872.60 2,686.45 +1.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.04 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-12 30.46 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-12 73.26 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 18.99 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 55.67 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.58 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.83 2,686.45 +1.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.72 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-12 4.36 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-12 7.77 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.69 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 10.82 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.98 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.71 2,686.45 +1.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,686.45 +1.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,686.45 +1.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,686.45 +1.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,686.45 +1.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,686.45 +1.9%

Aarti Drugs Ltd. FAQ's

What is Aarti Drugs share price?
Can I buy Aarti Drugs shares now?
What is the Dividend Yield of Aarti Drugs?
What is the Market Cap of Aarti Drugs?
What are the key metrics to analyse Aarti Drugs?
What is the 52 Week High and Low of Aarti Drugs?
What is the trend of Aarti Drugs share price?